These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34462295)

  • 61. Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy.
    Gonsalves WI; Rajkumar SV; Gertz MA; Dispenzieri A; Lacy MQ; Buadi FK; Dingli D; Go RS; Leung N; Kapoor P; Hayman SR; Lust JA; Russell SJ; Zeldenrust SR; Hwa YL; Kourelis TV; Kyle RA; Kumar SK
    Bone Marrow Transplant; 2016 Aug; 51(8):1156-8. PubMed ID: 27064687
    [No Abstract]   [Full Text] [Related]  

  • 62. Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial.
    Raje N; Vadhan-Raj S; Willenbacher W; Terpos E; Hungria V; Spencer A; Alexeeva Y; Facon T; Stewart AK; Feng A; Braun A; Balakumaran A; Roodman GD
    Blood Cancer J; 2016 Jan; 6(1):e378. PubMed ID: 26745852
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A rare esophageal complication after autologous stem cell transplantation.
    Lemmer A; Kia L; Cohen G
    Gastroenterology; 2015 Apr; 148(4):717-8. PubMed ID: 25721449
    [No Abstract]   [Full Text] [Related]  

  • 64. Is there a case for the early use of bisphosphonates in smouldering myeloma and MGUS? (Bisphosphonates in SMM & MGUS).
    Sanders J; Crawford B; Gibson J; Joy Ho P; Iland H; Joshua D
    Int J Lab Hematol; 2007 Oct; 29(5):395-7. PubMed ID: 17824924
    [No Abstract]   [Full Text] [Related]  

  • 65. Bisphosphonates in multiple myeloma: a fractured consensus.
    Kumar SK
    Leuk Lymphoma; 2015 Mar; 56(3):553-4. PubMed ID: 25224456
    [No Abstract]   [Full Text] [Related]  

  • 66. [Multiple myeloma].
    Abe M
    Nihon Rinsho; 2009 May; 67(5):991-5. PubMed ID: 19432122
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A novel case of follicular mucinosis after autologous stem-cell transplantation for multiple myeloma.
    Cheng S; Leach IH; Perkins W
    Clin Exp Dermatol; 2011 Aug; 36(6):635-7. PubMed ID: 21575038
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Treatment algorithms for multiple myeloma in Japan].
    Ozaki S
    Rinsho Ketsueki; 2017; 58(8):1014-1023. PubMed ID: 28883264
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial.
    Morgan GJ; Davies FE; Gregory WM; Szubert AJ; Bell SE; Drayson MT; Owen RG; Ashcroft AJ; Jackson GH; Child JA;
    Blood; 2012 Jun; 119(23):5374-83. PubMed ID: 22498739
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of multiple myeloma bone disease: experimental and clinical data.
    Papamerkouriou YM; Kenanidis E; Gamie Z; Papavasiliou K; Kostakos T; Potoupnis M; Sarris I; Tsiridis E; Kyrkos J
    Expert Opin Biol Ther; 2015 Feb; 15(2):213-30. PubMed ID: 25388648
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era.
    Tsukune Y; Sasaki M; Odajima T; Isoda A; Matsumoto M; Koike M; Tamura H; Moriya K; Ito S; Asahi M; Imai Y; Tanaka J; Handa H; Koiso H; Tanosaki S; Hua J; Hagihara M; Yahata Y; Suzuki S; Watanabe S; Sugimori H; Komatsu N
    Ann Hematol; 2016 Sep; 95(9):1465-72. PubMed ID: 27358178
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Myeloma kidney: improving clinical outcomes?
    Haynes R; Leung N; Kyle R; Winearls CG
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):342-51. PubMed ID: 22920645
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multiple myeloma treatment at relapse after autologous stem cell transplantation: A practical analysis.
    Malard F; Harousseau JL; Mohty M
    Cancer Treat Rev; 2017 Jan; 52():41-47. PubMed ID: 27888768
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High-dose melphalan followed by auto-SCT has favorable safety and efficacy in selected patients with light chain deposition disease and light and heavy chain deposition disease.
    Telio D; Shepherd J; Forrest D; Zypchen L; Barnett M; Nevill T; Song KW
    Bone Marrow Transplant; 2012 Mar; 47(3):453-5. PubMed ID: 21499318
    [No Abstract]   [Full Text] [Related]  

  • 75. Bisphosphonate treatment and renal function in 201 myeloma patients undergoing stem cell transplantation.
    Schmitt S; Hielscher T; Baldus C; Neben K; Egerer G; Hillengaß J; Raab M; Hose D; Ho AD; Bergner R; Goldschmidt H; Moehler TM
    Int J Hematol; 2013 Jun; 97(6):765-72. PubMed ID: 23616219
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study.
    Martino M; Montanari M; Ferrara F; Ciceri F; Scortechini I; Palmieri S; Marktel S; Cimminiello M; Messina G; Irrera G; Offidani M; Console G; Castagna L; Milone G; Bruno B; Tripepi G; Lemoli RM; Olivieri A;
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):1026-32. PubMed ID: 24699116
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Severe clavicular disease in multiple myeloma.
    Ferretti A; De Angelis G; Petrucci MT
    Br J Haematol; 2016 Jun; 173(6):820. PubMed ID: 27161803
    [No Abstract]   [Full Text] [Related]  

  • 78. Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients.
    O'Shea D; Giles C; Terpos E; Perz J; Politou M; Sana V; Naresh K; Lampert I; Samson D; Narat S; Kanfer E; Olavarria E; Apperley JF; Rahemtulla A
    Bone Marrow Transplant; 2006 Apr; 37(8):731-7. PubMed ID: 16501593
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The emerging role of consolidation and maintenance therapy for transplant-eligible multiple myeloma patients.
    McCarthy PL; Einsele H; Attal M; Giralt S
    Expert Rev Hematol; 2014 Feb; 7(1):55-66. PubMed ID: 24471885
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Further analyses of the Myeloma IX Study.
    Morgan GJ
    Lancet; 2011 Aug; 378(9793):768-9. PubMed ID: 21872746
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.